PRJNA867496
Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman Syndrome mouse model
The specificity and tolerability of a single injection of AAV-S1K therapy for Angelman Syndrome demonstrate the use of ATFs as a promising translational approach for AS.